Kazuto Chiba

Yokohama Rosai Hospital

Papers

3

Total Citations

21

H-Index

3

About

Dr. Kazuto Chiba is a pioneering urologic surgeon whose research centers on advancing surgical precision and personalized treatment for prostate and bladder cancers. His most impactful work focuses on refining robot-assisted radical prostatectomy (RARP) techniques to preserve nerve function and continence, as demonstrated in his landmark 2024 study (11 citations) evaluating long-term oncological and functional outcomes of a novel nerve-sparing approach with endopelvic fascia preservation. Dr. Chiba has also made significant contributions to precision oncology, notably reporting the first pathological complete response of plasmacytoid variant bladder cancer—a rare and aggressive malignancy—to pembrolizumab guided by genomic analysis (2022, 6 citations). His development and validation of a novel nomogram to identify candidates for extended pelvic lymph node dissection in Japanese prostate cancer patients (2023, 4 citations) provides a tailored, evidence-based tool for surgical decision-making in the robotic era. Through these achievements, Dr. Chiba exemplifies the integration of surgical innovation, genomic insight, and risk-stratified care, directly improving outcomes for patients with urologic malignancies.

Research Focus

Key Achievements

3
H-Index
3
Papers
21
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeon
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Yokohama Rosai Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago